全球医疗保健生物融合市场规模、份额、趋势和成长分析报告（2026-2034）

预计医疗保健生物融合市场将从 2025 年的 455.6 亿美元成长到 2034 年的 970.1 亿美元，2026 年至 2034 年的复合年增长率为 8.76%。

全球医疗生物融合市场代表着生物学、工程学、资料科学和尖端技术的融合。这种跨学科方法正在透过推动生物工程组织、智慧药物传输系统和先进诊断技术等创新，变革医疗保健产业。对个人化和高效医疗解决方案日益增长的需求，正在推动全球生物融合研发领域的投资。

生物技术、人工智慧和奈米技术的快速发展是推动该领域发展的主要动力。製药公司和医疗设备製造商正与科技公司合作，共同打造下一代医疗解决方案。精准倡议和再生医学研究领域资金的增加也促进了市场成长。学术机构和Start-Ups在加速该领域的创新方面发挥着至关重要的作用。

未来，生物融合有望彻底改变医疗保健领域的治疗方法和疾病管理。数位科技与生物系统的整合将改善病患监测和治疗效果。监管支持和跨行业伙伴关係对于加速创新至关重要。随着医疗保健系统向更加一体化和技术主导的模式转型，生物融合市场预计将在未来几年显着成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球医疗保健生物融合市场：依应用领域划分

• 市场分析、洞察与预测
• 药物发现
• 用于药物递送的奈米机器人
• 再生医学
• 诊断和生物感测器
• 生物电子学
• 工程化生命材料
• 光遗传学
• 精准医疗

第五章 全球医疗保健生物融合市场：依最终用户划分

• 市场分析、洞察与预测
• 製药和生物技术产业
• 合约研究组织（CRO）
• 其他的

第六章 全球医疗保健生物融合市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Ginkgo Bioworks
  • Thermo Fisher Scientific Inc
  • GE Healthcare
  • Siemens AG
  • BiomX
  • Century Therapeutics
  • Singota Solutions
  • Galvani Bioelectronics
  • Bico Group
  • SetPoint Medical

The Healthcare Bioconvergence Market size is expected to reach USD 97.01 Billion in 2034 from USD 45.56 Billion (2025) growing at a CAGR of 8.76% during 2026-2034.

The Global Healthcare Bioconvergence Market represents the integration of biology with engineering, data science, and advanced technologies. This interdisciplinary approach is transforming healthcare by enabling innovations such as bioengineered tissues, smart drug delivery systems, and advanced diagnostics. Growing demand for personalized and efficient healthcare solutions is driving investment in bioconvergence research and development worldwide.

Major drivers include rapid advancements in biotechnology, artificial intelligence, and nanotechnology. Pharmaceutical and medical device companies are collaborating with tech firms to create next-generation healthcare solutions. Increased funding for precision medicine initiatives and regenerative medicine research is also fueling market growth. Academic institutions and startups play a vital role in accelerating innovation in this field.

Looking forward, healthcare bioconvergence is expected to revolutionize treatment approaches and disease management. The integration of digital technologies with biological systems will enhance patient monitoring and therapeutic outcomes. Regulatory support and cross-industry partnerships will be essential for scaling innovations. As healthcare systems shift toward more integrated and technology-driven models, the bioconvergence market is poised for significant expansion in the years ahead.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Drug Discovery
• Nanorobotics for Drug Delivery
• Regenerative Medicine
• Diagnostic and Biological Sensor
• Bioelectronics
• Engineered Living Materials
• Optogenetics
• Precision Medicine

By End User

• Pharmaceutical & Biotechnology Industry
• Contract Research Organization (CRO)
• Others

COMPANIES PROFILED

• Ginkgo Bioworks, Thermo Fisher Scientific Inc, GE Healthcare, Siemens AG, BiomX, Century Therapeutics, Singota Solutions, Galvani Bioelectronics, Bico Group, SetPoint Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nanorobotics for Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Diagnostic and Biological Sensor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bioelectronics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Engineered Living Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Optogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Precision Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharmaceutical & Biotechnology Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Contract Research Organization (CRO) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE BIOCONVERGENCE MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE BIOCONVERGENCE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Ginkgo Bioworks
  • 8.2.2 Thermo Fisher Scientific Inc
  • 8.2.3 GE Healthcare
  • 8.2.4 Siemens AG
  • 8.2.5 BiomX
  • 8.2.6 Century Therapeutics
  • 8.2.7 Singota Solutions
  • 8.2.8 Galvani Bioelectronics
  • 8.2.9 Bico Group
  • 8.2.10 SetPoint Medical